DE3061921D1 - Process for preparing rhesus antigen, medicine and pharmaceutical compositions containing the antigen and administration forms - Google Patents

Process for preparing rhesus antigen, medicine and pharmaceutical compositions containing the antigen and administration forms

Info

Publication number
DE3061921D1
DE3061921D1 DE8080401540T DE3061921T DE3061921D1 DE 3061921 D1 DE3061921 D1 DE 3061921D1 DE 8080401540 T DE8080401540 T DE 8080401540T DE 3061921 T DE3061921 T DE 3061921T DE 3061921 D1 DE3061921 D1 DE 3061921D1
Authority
DE
Germany
Prior art keywords
antigen
solution
medicine
preparing
rhesus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8080401540T
Other languages
English (en)
Inventor
Simone Bierme
Madeleine Blanc
Michel Abbal
Alain Fournie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OEUVRE REG TRANSF SANGUINE
Original Assignee
OEUVRE REG TRANSF SANGUINE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by OEUVRE REG TRANSF SANGUINE filed Critical OEUVRE REG TRANSF SANGUINE
Application granted granted Critical
Publication of DE3061921D1 publication Critical patent/DE3061921D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE8080401540T 1979-10-31 1980-10-30 Process for preparing rhesus antigen, medicine and pharmaceutical compositions containing the antigen and administration forms Expired DE3061921D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7927080A FR2473312A1 (fr) 1979-10-31 1979-10-31 Preparation d'antigene rhesus administrable par voie orale, utile pour le traitement des formes graves d'immunisation rh

Publications (1)

Publication Number Publication Date
DE3061921D1 true DE3061921D1 (en) 1983-03-17

Family

ID=9231251

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8080401540T Expired DE3061921D1 (en) 1979-10-31 1980-10-30 Process for preparing rhesus antigen, medicine and pharmaceutical compositions containing the antigen and administration forms

Country Status (4)

Country Link
EP (1) EP0030172B1 (de)
AT (1) ATE2392T1 (de)
DE (1) DE3061921D1 (de)
FR (1) FR2473312A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106110421B (zh) * 2016-07-01 2019-02-01 翁炳焕 恒河猴红细胞吸附器

Also Published As

Publication number Publication date
ATE2392T1 (de) 1983-03-15
FR2473312B1 (de) 1983-03-25
EP0030172B1 (de) 1983-02-09
EP0030172A1 (de) 1981-06-10
FR2473312A1 (fr) 1981-07-17

Similar Documents

Publication Publication Date Title
Fishman Antibody formation in vitro
Pahwa et al. Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes.
Burnet et al. The" T" Antigen of Guinea-Pig and Human Red Cells.
NZ215867A (en) Aids envelope protein, dna vectors and method of production
Landy et al. Antibody production by leucocytes in peripheral blood
Lee et al. Characterization of the blastogenic and cytotoxic responses of normal mice to ecotropic C-type viral gp71
IE51174B1 (en) Group b streptococcal capsular polysaccharides
Viza et al. Solubilization and partial purification of human leukaemic specific antigens
US5610035A (en) Methods for the preparation of hybridomas producing lymphadenopathy-associated virus (LAV) GP110-specific monoclonal antibodies and methods for the purification of GP110 employing said monoclonal antibodies
DE3061921D1 (en) Process for preparing rhesus antigen, medicine and pharmaceutical compositions containing the antigen and administration forms
Duffus et al. Initial studies on the properties of a bovine lymphoid cell culture line infected with Theileria parva
Collins et al. Immunotherapy of murine leukemia. I. Protection against Friend leukemia virus‐induced disease by passive serum therapy
Mergenhagen Complement as a mediator of the inflammatory response: interaction of complement with mammalian and bacterial enzymes
Warnatz et al. Studies on the specificity of in vitro induced lymphocytotoxicity to SV40-transformed fibroblasts
FR2607703B1 (fr) Polypeptides a action immunologique, leur procede de preparation, et leur utilisation pour la preparation de vaccins antipaludeens et de trousses de diagnostic pour la detection d'anticorps antisporozoaires
Hengst et al. Immunological effects of recombinant interferon-α2 in cancer patients
McMeekin et al. Heterogeneity of crystalline beta-lactoglobulin
GB1404225A (en) Extraction of physiologically active substrates from parathyroid
Le Bouvier Physicochemical characteristics of rubella antigens theta and iota
US3829361A (en) Method for attenuation of mumps virus
JPS55159158A (en) Novel reagent for separation of lipoprotein
AT344885B (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praeparaten
US5407811A (en) Monoclonal antibodies to GP110 of HIV and hybridomas secreting these antibodies
Greger et al. Micro-electrophoresis of human white cells and platelets
EP0251460A3 (en) Method for producing hepatitis b virus core antigen (hbcag) in yeast

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee